Dihydrotanshinone I (DHI) has been shown to have an effect on the expression of ferroptosis-related proteins in GBM, which downregulates GPX4 and intracellular GSH levels by increasing the expression of ACSL4 [88]. Here, GPX4 is linked to glioblastoma.